NCT00257556 - A Study of the Efficacy and Safety of Highly Purified Menotrophin Versus Recombinant Follitropin Alfa | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

July 31, 2008

Study Completion Date

April 30, 2009

Conditions

Infertility

Interventions

DRUG

Menotrophin

150 IU Menotrophin daily subcutaneous injection for a maximum of 13 days. In the event of hyperstimulation, the dose was reduced to 75 IU daily.

DRUG

Follitropin alfa

150 IU follitropin alfa daily by subcutaneous injection for a maximum of 13 days. In the event of hyperstimulation, the dose was reduced to 75 IU daily.

Trial Locations (6)

1134

Gemeinschaftspraxis und Tagesklinik, Zingel 29, Hildesheim

44135

Gemeinschaftspraxis und Tagesklinik, Olpe 19, Dortmund

69115

Universitats-Frauenklinik Heidelberg Abt. Gynakologische Endokrinologie und Fertilitatsstorungen, Voßstr. 9, Heidelberg

EH16 4SA

Royal Infirmary of Edinburgh, 51 Little France, Edinburgh

LS1 3EX

Leeds General Infirmary, Great George Street, Leeds

S10 2SF

The Royal Hallamshire Hospital, University of Sheffield, Jessop Wing, Tree Root Walk, Sheffield